CHM chimeric therapeutics limited

CHM don’t need to dose all 15 patients for the CDH17 CART trial....

  1. 294 Posts.
    lightbulb Created with Sketch. 92
    CHM don’t need to dose all 15 patients for the CDH17 CART trial. They will hopefully complete dose escalation at patient 9. The remaining 6 patients give the company flexibility to go up or down a dose if they want more data.

    furthermore the company is on record saying that partnering for the phase 2 trial is on the cards. The mid year ASCO conference will be instrumental for that.
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
0.4¢
Change
0.000(0.00%)
Mkt cap ! $8.060M
Open High Low Value Volume
0.5¢ 0.5¢ 0.4¢ $432 98K

Buyers (Bids)

No. Vol. Price($)
26 22188206 0.4¢
 

Sellers (Offers)

Price($) Vol. No.
0.5¢ 25892021 31
View Market Depth
Last trade - 13.15pm 16/06/2025 (20 minute delay) ?
CHM (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.